Alta, Rowena O.

HRN: 18-43-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2023
CEFUROXIME 1.5GM (VIAL)
01/23/2023
01/30/2023
IV
1.5g
Q8hrs
Cholecystolithiases
Waiting Final Action 
01/24/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/24/2023
01/31/2023
IV
500mg
Q8H
Cholecystectomy
Waiting Final Action 
01/27/2023
CEFUROXIME 500MG (TAB)
01/27/2023
02/03/2023
PO
500mg
Q12hrs
Post Cholecystectomy
Waiting Final Action 
01/27/2023
METRONIDAZOLE 500MG (TAB)
01/27/2023
02/03/2023
PO
500mg
Q8hrs
S/p Cholecystectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: